Related Experiment Video
Updated: Jun 14, 2026

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
Global trends in the prevalence of type 2 diabetes mellitus: understanding trajectories through conceptual frameworks
Deepa Bharti1, Madhur Verma2, Sanjay Kalra3,4
1Department of Community and Family Medicine, All India Institute of Medical Sciences, Bathinda, Punjab, 151001, India.
Background:
Type 2 diabetes mellitus (T2DM) is imposing a substantial and rapidly growing global health burden. Disease estimates vary widely across geographies and time periods, reflecting not only true differences in disease occurrence but also variation in demographic structures, risk factor exposures, diagnostic practices, surveillance capacity, and biological heterogeneity within T2DM itself.
Methods:
A narrative, integrative synthesis of global epidemiological evidence was conducted. Data were sourced from major international platforms, supplemented with peer-reviewed literature. Evidence was synthesized across time, place, and person, with explicit attention to differences in case definitions, biomarker use, screening intensity, and modeling assumptions. Conceptual frameworks were applied to interpret observed patterns.
Results:
Harmonized NCD-RisC analyses show a sustained rise in age-standardized prevalence from 1980 to 2014, increasing from 4.3% to 9.0% in men and from 5.0% to 7.9% in women. According to the IDF, the global burden is projected to reach 852.5 million by 2050. Approximately 42.8% (251.7 million) of cases remain undiagnosed, with the highest proportions concentrated in low-income regions. Substantial geographic heterogeneity is shaped by population aging, rising adiposity, dietary and physical activity transitions, urbanization, commercial food environments, and health system detection capacity. Subtype distribution and biological heterogeneity further contribute to variation in disease trajectories and complication profiles across populations.
Conclusions:
Global T2DM prevalence reflects the interaction of biological, social, and health system processes rather than incidence alone. Prevalence trajectories must be interpreted in light of surveillance limitations, diagnostic context, and within-disease heterogeneity. Addressing future burden requires combining improved detection and chronic-care capacity with upstream, life-course-oriented prevention strategies.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Type II Diabetes I: Introduction
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type II Diabetes II: Pathophysiology
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...